多剤併用療法レジメンによる多剤併用療法レジメンによる再発および新規耐性、米国、2022-2024年
Rina Liang1, James C M Brust1, Caitlin Reed2
1Department of Medicine, Division of Infectious Diseases, Albert Einstein College of Medicine & Montefiore Medical Center, Bronx, New York, USA.
Open forum infectious diseases
|January 16, 2026
まとめ
ベダキリン、プレトマニド、リネゾリド(BPaL/M)レジメンによる薬剤耐性結核の治療を受けた患者において、治療失敗および再発が発生しました。これらの結果は、多剤併用療法レジメンによる結核患者の専門的な管理と綿密なモニタリングの必要性を強調しています。
科学分野:
- 感染症
- 公衆衛生
- 臨床医学
背景:
- ベダキリン、プレトマニド、リネゾリド、およびモキシフロキサシン(BPaL/M)は、多剤併用療法またはリファンピシン耐性(MDR/RR)結核(TB)に対して推奨される6ヶ月間の経口治療レジメンです。
- 米国での2019年の展開以来、これらのレジメンを受けている患者において、治療失敗や再発を含む有害事象が特定されています。
主な方法:
- 2022年から2024年の間にBPaL/Mレジメンで治療された米国結核患者の症例シリーズを分析しました。
- 特定された患者の臨床的および公衆衛生上の転帰を文書化しました。
結論:
- 現実世界のデータは、BPaL/Mレジメンによる再発および治療失敗の重大な結果を明らかにしています。
- 新しいレジメンにもかかわらず、米国の臨床医は薬剤耐性結核の管理に課題を抱えています。
- 治療後の薬剤耐性結核患者には、専門的な管理、綿密なモニタリング、およびフォローアップが不可欠です。
関連する概念動画
Pulmonary Tuberculosis V
543
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
543
Pulmonary Tuberculosis I
844
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
844
Pulmonary Tuberculosis II
1.4K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.4K
Pulmonary Tuberculosis IV
479
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
479
Development of Antibiotic Resistance
1.3K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.3K
Pulmonary Tuberculosis III
941
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
941


